Survival after adding capecitabine and trastuzumab to neoadjuvant anthracycline-taxane-based chemotherapy for primary breast cancer (GBG 40—GeparQuattro)
Titel:
Survival after adding capecitabine and trastuzumab to neoadjuvant anthracycline-taxane-based chemotherapy for primary breast cancer (GBG 40—GeparQuattro)
Auteur:
von Minckwitz, G. Rezai, M. Fasching, P.A. Huober, J. Tesch, H. Bauerfeind, I. Hilfrich, J. Eidtmann, H. Gerber, B. Hanusch, C. Blohmer, J.U. Costa, S.D. Jackisch, C. Paepke, S. Schneeweiss, A. Kümmel, S. Denkert, C. Mehta, K. Loibl, S. Untch, M.